Cargando…

Drugs in psychiatric practice /

Drugs in Psychiatric Practice present a comprehensive examination of the drug treatment in psychiatry. It discusses certain ways in which drugs behaved. It addresses the advances in pharmacology and the basis of prescription. Some of the topics covered in the book are the classification of psychotro...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Tyrer, Peter J.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London ; Boston : Butterworths, 1982.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 SCIDIR_ocn560762795
003 OCoLC
005 20231117032924.0
006 m o d
007 cr bn||||||abp
007 cr bn||||||ada
008 100318s1982 enka o 000 0 eng d
040 |a OCLCE  |b eng  |e pn  |c OCLCE  |d OCLCQ  |d UIU  |d OCLCF  |d E7B  |d N$T  |d YDXCP  |d EBLCP  |d OCLCQ  |d MERUC  |d OCLCO  |d OCLCQ  |d STF  |d UKAHL  |d OCLCQ  |d OCLCO  |d OCLCA  |d VLY  |d OCLCA  |d OCLCQ  |d OCLCO  |d OCL  |d OCLCQ  |d OCLCO 
019 |a 896795709  |a 907118282  |a 974614079  |a 974661897  |a 1100972694  |a 1153493926  |a 1162285305  |a 1397440468 
020 |a 9781483191935  |q (electronic bk.) 
020 |a 1483191931  |q (electronic bk.) 
020 |z 040700212X 
020 |z 9780407002128 
035 |a (OCoLC)560762795  |z (OCoLC)896795709  |z (OCoLC)907118282  |z (OCoLC)974614079  |z (OCoLC)974661897  |z (OCoLC)1100972694  |z (OCoLC)1153493926  |z (OCoLC)1162285305  |z (OCoLC)1397440468 
042 |a dlr 
050 4 |a RM315 
060 4 |a QV 77  |b D794 1982 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
082 0 4 |a 616.89/18  |2 19 
082 0 4 |a 615/.78  |2 19 
245 0 0 |a Drugs in psychiatric practice /  |c edited by Peter J. Tyrer. 
260 |a London ;  |a Boston :  |b Butterworths,  |c 1982. 
300 |a 1 online resource (xii, 442 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 |3 Use copy  |f Restrictions unspecified  |2 star  |5 MiAaHDL 
533 |a Electronic reproduction.  |b [Place of publication not identified] :  |c HathiTrust Digital Library,  |d 2010.  |5 MiAaHDL 
538 |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.  |u http://purl.oclc.org/DLF/benchrepro0212  |5 MiAaHDL 
583 1 |a digitized  |c 2010  |h HathiTrust Digital Library  |l committed to preserve  |2 pda  |5 MiAaHDL 
588 0 |a Print version record. 
504 |a ReferencesChapter 6. Antianxiety drugs; Generalized central anxiolytics (sedative drugs); Specific central anxiolytics (ataractic drugs); Combined preparations including antianxiety drugs; Peripheral anxiolytics; Comparison of antianxiety drugs; References; Chapter 7. Tricyclic antidepressants; Introduction; Pharmacology; Pharmacokinetics; Clinical use; Introduction of amitriptyline; Other tricyclic antidepressant drugs; Comparisons between tricyclic drugs and other antidepressive treatments; Tricyclic drugs in the treatment of enuresis; General topics concerning the tricyclic drugs. 
505 0 |a Front Cover; Drugs in Psychiatric Practice; Copyright Page; Preface; Contributors; Table of Contents; Introduction; References; Chapter 1. Classification of psychotropic drugs; What is a psychotropic drug?; Types of classification; Classification of drugs used in this book; References; Chapter 2. Pharmacokinetics and drug metabolismbasic principles; Definitions and basic principles in pharmacokinetics; Multiple administration; Absorption; Protein binding and distribution; Metabolism; Excretion; Pharmacokinetics and pharmacological effect; Conclusions; References. 
505 8 |a Chapter 3. Evaluation of psychotropic drugsAnimal studies; Experimental studies in volunteers; Experimental studies in patients; Early clinical trials; Marketing; Early and late clinical evaluation; References; Chapter 4. Antischizophrenic drugs; Introduction; Nomenclature; Unconventional chemotherapy; Pharmacology; Non-DA-related pharmacology; Pharmacokinetics; Clinical efficacy; Unwanted effects; References; Chapter 5. Antiparkinsonian and antidyskinetic drugs; Introduction; Pathophysiology of neuroleptic-induced movement disorders; Drug treatment of neuroleptic-induced movement disorders. 
505 8 |a Unwanted effectsReferences; Chapter 8. New generation of antidepressants; Tricyclic antidepressants; MAO inhibitors; Maprotiline (Ludiomil); Mianserin (Bolvidon, Norval); Flupenthixol (Fluanxol); Nomifensine (Merital); Trazodone (Molipaxin); Zimelidine; Comments; Summary; References; Chapter 9. Monoamine oxidase inhibitors and amine precursors; Pharmacology; Pharmacokinetics; Dosage and clinical response; Unwanted effects; Individual monoamine oxidase inhibitors; Main clinical indications for MAOIs; Amine precursors; Summary; References; Chapter 10. Lithium carbonate. 
505 8 |a Introduction and historical aspectsPharmacology; Pharmacokinetics; Determination of lithium concentration; Lithium preparations; Clinical use; Treatment of depression with lithium; Lithium and schizoaffective disorders; Lithium and other conditions; Unwanted effects; Drug interactions; Unwanted and toxic effects of lithium; Acknowledgements; References; Chapter 11. Psychostimulants; Introduction; Pharmacology; Pharmacokinetics; Clinical efficacy; Methylphenidate; Other psychostimulants; Drug interactions; References; Chapter 12. Drugs of dependence; Controlled drugs; Opiate drugs. 
520 |a Drugs in Psychiatric Practice present a comprehensive examination of the drug treatment in psychiatry. It discusses certain ways in which drugs behaved. It addresses the advances in pharmacology and the basis of prescription. Some of the topics covered in the book are the classification of psychotropic drugs; basic principles of pharmacokinetics and drug metabolism; anti-schizophrenic drugs; evaluation of psychotropic drugs; unconventional chemotherapy; anti-parkinsonian and anti-dyskinetic drugs; introduction of amitriptyline; and tricyclic antidepressants. The role of tricyclic drugs in the. 
546 |a English. 
650 0 |a Psychotropic drugs. 
650 0 |a Psychopharmacology. 
650 2 |a Psychopharmacology  |0 (DNLM)D011600 
650 2 |a Psychotropic Drugs  |x therapeutic use  |0 (DNLM)D011619Q000627 
650 2 |a Psychotropic Drugs  |0 (DNLM)D011619 
650 6 |a Psychopharmacologie.  |0 (CaQQLa)201-0020955 
650 6 |a Psychotropes.  |0 (CaQQLa)201-0001454 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Psychopharmacology  |2 fast  |0 (OCoLC)fst01081659 
650 7 |a Psychotropic drugs  |2 fast  |0 (OCoLC)fst01081826 
653 |a Psychotropic drugs 
700 1 |a Tyrer, Peter J. 
776 0 8 |i Print version:  |t Drugs in psychiatric practice.  |d London ; Boston : Butterworths, 1982  |w (OCoLC)11043852 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780407002128  |z Texto completo